Abstract:Background: Vascular smooth muscle cells (VSMCs) show a remarkable phenotypic plasticity, allowing acquisition of contractile or synthetic states, but critical information is missing about the physiologic signals, promoting formation, and maintenance of contractile VSMCs in vivo. BMP9 and BMP10 (bone morphogenetic protein) are known to regulate endothelial quiescence after secretion from the liver and right atrium, whereas a direct role in the regulation of VSMCs was not investigated. We studied the role of BMP9 and BMP10 for controlling formation of contractile VSMCs. Methods: We generated several cell type-specific loss- and gain-of-function transgenic mouse models to investigate the physiologic role of BMP9, BMP10, ALK1 (activin receptor-like kinase 1), and SMAD7 in vivo. Morphometric assessments, expression analysis, blood pressure measurements, and single molecule fluorescence in situ hybridization were performed together with analysis of isolated pulmonary VSMCs to unravel phenotypic and transcriptomic changes in response to absence or presence of BMP9 and BMP10. Results: Concomitant genetic inactivation of Bmp9 in the germ line and Bmp10 in the right atrium led to dramatic changes in vascular tone and diminution of the VSMC layer with attenuated contractility and decreased systemic as well as right ventricular systolic pressure. On the contrary, overexpression of Bmp10 in endothelial cells of adult mice dramatically enhanced formation of contractile VSMCs and increased systemic blood pressure as well as right ventricular systolic pressure. Likewise, BMP9/10 treatment induced an ALK1-dependent phenotypic switch from synthetic to contractile in pulmonary VSMCs. Smooth muscle cell-specific overexpression of Smad7 completely suppressed differentiation and proliferation of VSMCs and reiterated defects observed in adult Bmp9/10 double mutants. Deletion of Alk1 in VSMCs recapitulated the Bmp9/10 phenotype in pulmonary but not in aortic and coronary arteries. Bulk expression analysis and single molecule RNA-fluorescence in situ hybridization uncovered vessel bed-specific, heterogeneous expression of BMP type 1 receptors, explaining phenotypic differences in different Alk1 mutant vessel beds. Conclusions: Our study demonstrates that BMP9 and BMP10 act directly on VSMCs for induction and maintenance of their contractile state. The effects of BMP9/10 in VSMCs are mediated by different combinations of BMP type 1 receptors in a vessel bed-specific manner, offering new opportunities to manipulate blood pressure in the pulmonary circulation.

Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.

Requirements of Myocyte-Specific Enhancer Factor 2a in Zebrafish Cardiac Contractility

The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation

Bmp2 regulates the interaction between EPDCs and myocytes in cardiac OFT.

BMP10 preserves cardiac function through its dual activation of SMAD-mediated and STAT3-mediated pathways

An in vivo map of bone morphogenetic protein 2 post-transcriptional repression in the heart

Mechanisms of Signal Transduction in Bone Morphogenetic Protein-2-induced Cardiomyocyte Differentiation of Cardiac Stem Cells

The Function of the MEF2 Family of Transcription Factors in Cardiac Development, Cardiogenomics, and Direct Reprogramming

EphrinB2 Regulates Cardiac Fibrosis Through Modulating the Interaction of Stat3 and TGF-β/Smad3 Signaling

Abstract 13999: Atrial-Specific BetaM Protein is a Novel Transcriptional Regulator of Cardiac Hypertrophic Response and Myogenesis

Contraction-induced endocardial id2b plays a dual role in regulating myocardial contractility and valve formation

Myocyte Enhancer Factor 2C and Its Directly-Interacting Proteins: A Review

Translation of Myocyte Enhancer Factor-2 is Induced by Hypertrophic Stimuli in Cardiomyocytes Through a Calcineurin-dependent Pathway.

Tbx20 Transcription Factor is a Downstream Mediator for Bone Morphogenetic Protein-10 in Regulating Cardiac Ventricular Wall Development and Function

Efficient Cardiomyogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells by Combination of Wnt11 and Bone Morphogenetic Protein 2

Bone Morphogenic Protein-2 Regulates the Myogenic Differentiation of PMVECs in CBDL Rat Serum-Induced Pulmonary Microvascular Remodeling.

BMP and Notch Signaling Pathways differentially regulate Cardiomyocyte Proliferation during Ventricle Regeneration

Cooperative Interaction between the Basic Helix-loop-helix Transcription Factor dHAND and Myocyte Enhancer Factor 2C Regulates Myocardial Gene Expression

The Cardiac Determination Factor, Nkx2-5, is Activated by Mutual Cofactors GATA-4 and Smad1/4 Via a Novel Upstream Enhancer

BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.

Efficient Cardiomyocyte Differentiation of Embryonic Stem Cells by Bone Morphogenetic Protein-2 Combined with Visceral Endoderm-Like Cells.